Publications by authors named "Mathias J Rummel"

18Publications

Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).

Eur J Haematol 2012 Feb 22;88(2):167-74. Epub 2011 Nov 22.

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.

View Article and Find Full Text PDF
February 2012

Bendamustine's emerging role in the management of lymphoid malignancies.

Semin Hematol 2011 Apr;48 Suppl 1:S24-36

Universitätsklinikum, Giessen, Germany.

View Article and Find Full Text PDF
April 2011

Clinical Roundtable Monograph: recent advances in NHL. Highlights from the 51st ASH Annual Meeting and Exposition, December 5-8, 2009, New Orleans, Louisiana.

Clin Adv Hematol Oncol 2010 Feb;8(2):A1-11

Lymphoma/Myeloma Service, Lymphoma Translational Research Laboratory, Roswell Park Cancer Institute, Buffalo, New York, USA.

View Article and Find Full Text PDF
February 2010

[Hairy cell leukemia: Part II: therapy with cladribine].

Med Monatsschr Pharm 2009 Jul;32(7):252-60

Medizinische Klinik und Poliklinik IV des Universitätsklinikums Giessen, Klinikstrasse 36, 35385 Giessen.

View Article and Find Full Text PDF
July 2009

[Hairy cell leukemia: Part I: disease pattern and common therapy].

Med Monatsschr Pharm 2009 Jul;32(7):249-51

Medizinische Klinik und Poliklinik IV des Universitätsklinikums Giessen, Klinikstrasse 36, 35385 Giessen.

View Article and Find Full Text PDF
July 2009

Bendamustine: rebirth of an old drug.

J Clin Oncol 2009 Mar 17;27(9):1492-501. Epub 2009 Feb 17.

Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC 20007, USA.

View Article and Find Full Text PDF
March 2009

Bendamustine in chronic lymphocytic leukemia and refractory lymphoma.

Authors:
Mathias J Rummel

Semin Hematol 2008 Jul;45(3 Suppl 2):S7-10

Department of Hematology, Hospital of the Justus-Liebig-University of Giessen, Giessen, Germany.

View Article and Find Full Text PDF
July 2008

Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone.

Int J Hematol 2004 May;79(4):311-21

Section of Oncology/Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA.

View Article and Find Full Text PDF
May 2004

Altered apoptosis pathways in mantle cell lymphoma.

Leuk Lymphoma 2004 Jan;45(1):49-54

Departament of Hematology, University Hospital, Frankfurt/Main, Germany.

View Article and Find Full Text PDF
January 2004

Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.

Semin Oncol 2002 Aug;29(4 Suppl 13):27-32

Department of Hämatologie/Onkologie, Medizinische Universitätsklinik, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.

View Article and Find Full Text PDF
August 2002

In vitro studies with bendamustine: enhanced activity in combination with rituximab.

Semin Oncol 2002 Aug;29(4 Suppl 13):12-4

Department of Internal Medicine III, Hematology and Oncology, University Hospital, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.

View Article and Find Full Text PDF
August 2002